STAT August 15, 2024
Switching to IV treatments cuts out-of-pocket expenses but carries risks
As many as 40,000 chronically ill seniors are choosing to endure uncomfortable, time-consuming intravenous infusions because Medicare doesn’t sufficiently cover far more convenient, and less distressing, at-home treatments with the arthritis drug Humira.
When rheumatoid arthritis patients enroll in...